{"id":2389,"date":"2012-12-27T12:09:11","date_gmt":"2012-12-27T12:09:11","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/retinopathy-of-prematurity\/"},"modified":"2025-05-13T20:28:17","modified_gmt":"2025-05-13T20:28:17","slug":"retinopathy-of-prematurity","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/es\/retinopathy-of-prematurity\/","title":{"rendered":"Clasificaci\u00f3n de la Retinopat\u00eda del Prematuro (RP)"},"content":{"rendered":"<div class=\"7ca9444b8380138fe077da07353677a4\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p><span id=\"result_box\" lang=\"es\"><span title=\"Retinopathy of prematurity is a vision-threatening disease associated with abnormal retinal vascular development that occurs only in premature infants.\">La retinopat\u00eda del prematuro es una enfermedad que afecta la visi\u00f3n asociada con el desarrollo\u00a0<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Retinopathy of prematurity is a vision-threatening disease associated with abnormal retinal vascular development that occurs only in premature infants.\">vascular<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Retinopathy of prematurity is a vision-threatening disease associated with abnormal retinal vascular development that occurs only in premature infants.\">\u00a0<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Retinopathy of prematurity is a vision-threatening disease associated with abnormal retinal vascular development that occurs only in premature infants.\">anormal\u00a0<\/span><\/span><span id=\"result_box\" lang=\"es\"><\/span><span id=\"result_box\" lang=\"es\"><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Retinopathy of prematurity is a vision-threatening disease associated with abnormal retinal vascular development that occurs only in premature infants.\">de la retina\u00a0<\/span><\/span><span id=\"result_box\" lang=\"es\"><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Retinopathy of prematurity is a vision-threatening disease associated with abnormal retinal vascular development that occurs only in premature infants.\">que se produce solo en infantes prematuros.<\/span><\/span><br \/>\n<!--more--><br \/>\n<span title=\"Criteria for screening\"><strong>Criterios para screening<\/strong><br \/>\n<\/span><\/p>\n<ul>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"United States: infants with a gestational age of ?30 weeks or birth weight of &lt;1500 g and selected infants with a gestational age of &gt;30 weeks and an unstable clinical course\">Estados Unidos: reci\u00e9n nacidos con una edad gestacional\u00a0<\/span><\/span>&lt;\/=<span id=\"result_box\" lang=\"es\"><span title=\"United States: infants with a gestational age of ?30 weeks or birth weight of &lt;1500 g and selected infants with a gestational age of &gt;30 weeks and an unstable clinical course\">30 semanas o con peso al nacer &lt;1500 g, e infantes seleccionados con edad gestacional &gt;30 semanas y un curso cl\u00ednico inestable<\/span><\/span><\/li>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"United Kingdom: infants with a gestational age of &lt;\/=31 weeks or birth weight of &lt;\/=1500 g\">Reino Unido: reci\u00e9n nacidos con una edad gestacional &lt;\/= 31 semanas o con peso al nacer &lt;\/= 1500 g<br \/>\n<\/span><\/span><\/li>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"Canada: infants with a gestational age of &lt;\/=30 weeks, 6 days, or birth weight of &lt;\/=1250 g\">Canad\u00e1: reci\u00e9n nacidos con una edad gestacional &lt;\/= 30 semanas, 6 d\u00edas, o con peso al nacer &lt;\/= 1250 g<\/span><\/span><\/li>\n<\/ul>\n<p><span id=\"result_box\" lang=\"es\"><span title=\"Canada: infants with a gestational age of &lt;\/=30 weeks, 6 days, or birth weight of &lt;\/=1250 g\"><br \/>\n<\/span><span title=\"Timing of screening and examinations\"><strong>Momento de evaluaci\u00f3n y ex\u00e1menes<\/strong><br \/>\n<\/span><\/span><\/p>\n<ul>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"First examination at chronologic age of 4\u20136 weeks or postgestational age of 31 weeks\">Primer examen a la edad cronol\u00f3gica de 4-6 semanas o edad postgestacional de 31 semanas<\/span><\/span><\/li>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"Repeated examinations recommended by examining ophthalmologist on the basis of retinal findings and suggested schedule\">Ex\u00e1menes repetidos recomendados por el<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Repeated examinations recommended by examining ophthalmologist on the basis of retinal findings and suggested schedule\">\u00a0oftalm\u00f3logo<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Repeated examinations recommended by examining ophthalmologist on the basis of retinal findings and suggested schedule\">\u00a0examinador sobre la base de los resultados de la retina y periodicidad sugerida<\/span><\/span><\/li>\n<\/ul>\n<p><span id=\"result_box\" lang=\"es\"><span title=\"Type of examination\"><strong>Tipo de examen<\/strong><br \/>\n<\/span><\/span><\/p>\n<ul>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"Dilated binocular indirect ophthalmoscopy\">Oftalmoscopia indirecta binocular dilatada<\/span><\/span><\/li>\n<li><span id=\"result_box\" lang=\"es\"><span title=\"Ongoing studies of validation and reliability of retinal imaging as a potential telemedicine alternative for screening by indirect ophthalmoscopy\">Los estudios en curso de validaci\u00f3n y confiabilidad de im\u00e1genes de retina como una alternativa potencial<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Ongoing studies of validation and reliability of retinal imaging as a potential telemedicine alternative for screening by indirect ophthalmoscopy\">\u00a0de telemedicina<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Ongoing studies of validation and reliability of retinal imaging as a potential telemedicine alternative for screening by indirect ophthalmoscopy\">\u00a0para la detecci\u00f3n por oftalmoscopia indirecta<\/span><\/span><\/li>\n<\/ul>\n<p><span id=\"result_box\" lang=\"es\"><span title=\"Classification of retinopathy of prematurity determined in examinations\"><strong>Clasificaci\u00f3n de retinopat\u00eda del prematuro determinado en los ex\u00e1menes<\/strong><br \/>\n<\/span><\/span><\/p>\n<p><span id=\"result_box\" lang=\"es\"><span title=\"Zone (area of retinal vascularization)\">Zona (\u00e1rea de vascularizaci\u00f3n de retina)<\/span><\/span><br \/>\n<span id=\"result_box\" lang=\"es\"><span title=\"I: vascularization within a circle centered on the optic nerve, the radius of which is twice the distance from the optic nerve to the macula\">I: vascularizaci\u00f3n dentro de un c\u00edrculo centrado en el nervio \u00f3ptico, cuyo radio es el doble de la distancia desde el nervio \u00f3ptico hasta la m\u00e1cula<br \/>\n<\/span><span title=\"II: vascularization extending beyond zone I, within a circle the radius of which is the distance from the optic nerve to the nasal ora serrata\">II: vascularizaci\u00f3n extendida m\u00e1s all\u00e1 de la zona I, dentro de un c\u00edrculo cuyo radio es la distancia desde el nervio \u00f3ptico hasta la ora serrata nasal<br \/>\n<\/span><span title=\"III: vascularization extending beyond zones I and II\">III: vascularizaci\u00f3n extendida m\u00e1s all\u00e1 de las zonas I y II<\/span><\/span><br \/>\n<span id=\"result_box\" lang=\"es\"><span title=\"III: vascularization extending beyond zones I and II\"><br \/>\n<\/span><span title=\"Stage (disease severity)\">Estadio (severidad de la enfermedad)<\/span><\/span><br \/>\n<span id=\"result_box\" lang=\"es\"><span title=\"1: line\">1: l\u00ednea<br \/>\n<\/span><span title=\"2: ridge (with volume)\">2: canto (con volumen)<br \/>\n<\/span><span title=\"3: intravitreal angiogenesis\">3: angiog\u00e9nesis intrav\u00edtrea<br \/>\n<\/span><span title=\"4: partial retinal detachment\">4: desprendimiento parcial de la retina<br \/>\n<\/span><span title=\"5: total retinal detachment\">5: desprendimiento total de retina<br \/>\n<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Plus disease: dilatation and tortuosity of retinal vessels\">Enfermedad\u00a0<\/span><\/span><span id=\"result_box\" lang=\"es\"><span title=\"Plus disease: dilatation and tortuosity of retinal vessels\">Plus: dilataci\u00f3n y tortuosidad de los vasos retinianos<br \/>\n<\/span><\/span><br \/>\n<span id=\"result_box\" lang=\"es\"><span title=\"Treatment\"><strong>Tratamiento<\/strong><br \/>\n<\/span><span title=\"Application of laser to peripheral avascular retina for type 1 retinopathy of prematurity\">Aplicaci\u00f3n de l\u00e1ser a la retina avascular perif\u00e9rica<\/span><\/span>\u00a0con\u00a0retinopat\u00eda\u00a0tipo 1 del prematuro<br \/>\n<span lang=\"es\"><span title=\"Zone I: stage 3, or stage 1 or 2 with plus disease\">Zona I: estadio 3, o estadio 1 o 2 con enfermedad plus<br \/>\n<\/span><span title=\"Zone II: stage 2 or 3 with plus disease\">Zona II: estadio 2 o 3 con enfermedad plus<br \/>\n<\/span><\/span><br \/>\n<span lang=\"es\"><span title=\"Under consideration, anti-VEGF agents for stage 3 and plus disease in zone I; additional study needed to determine dose, safety, and type of anti-VEGF therapy*\">Bajo consideraci\u00f3n, agentes anti-VEGF para etapa 3 y enfermedad plus en zona I; estudios adicionales son necesarios para determinar la dosis, la seguridad, y el tipo de terapia anti-VEGF *<br \/>\n<\/span><\/span><\/p>\n<p><span lang=\"es\"><span title=\"Visual rehabilitation\"><strong>Rehabilitaci\u00f3n visual<\/strong><br \/>\n<\/span><span title=\"Correction often needed for associated refractive errors (ametropia and anisometropia); ongoing screening and treatment recommended for commonly associated amblyopia or strabismus; protective eyewear and low-vision aids may be indicated\">La correcci\u00f3n es a menudo necesaria para errores refractivos asociados (ametrop\u00eda y anisometrop\u00eda); la evaluaci\u00f3n en curso y el tratamiento recomendado para la ambliop\u00eda o estrabismo asociados com\u00fanmente; gafas de protecci\u00f3n y ayudas de baja visi\u00f3n pueden estar indicadas.<br \/>\n<\/span><span title=\"* VEGF denotes vascular endothelial growth factor.\">*\u00a0<\/span><\/span>VEGF\u00a0denota factor de crecimiento endotelial vascular.<br \/>\n<span lang=\"es\"><span title=\"* VEGF denotes vascular endothelial growth factor.\"><br \/>\n<\/span><\/span><\/p>\n<p><span lang=\"es\"><span title=\"References:\"><strong>Bibliograf\u00eda:<\/strong><br \/>\n<\/span><\/span><\/p>\n<ol>\n<li>Hartnett ME, Penn JS. Mechanisms and Management of Retinopathy of Prematurity. N Engl J Med 2012;367(26):2515-2526 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23268666\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>Quiram PA, Capone A Jr. Current understanding and management of retinopathy of prematurity. Curr Opin Ophthalmol. 2007 May;18(3):228-34. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17435431\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<\/ol>\n<p><span lang=\"es\"><span title=\"References:\"><br \/>\n<\/span><span title=\"Created Dic 27, 2012.\">Creado Dic 27, 2012.<\/span><\/span><\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>La retinopat\u00eda del prematuro es una enfermedad que afecta la visi\u00f3n asociada con el desarrollo\u00a0vascular\u00a0anormal\u00a0de la retina\u00a0que se produce solo en infantes prematuros.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[441],"tags":[166,167,1058,1059,1060,1061],"class_list":["post-2389","post","type-post","status-publish","format-standard","hentry","category-pediatrics","tag-clasificacion","tag-classification","tag-prematurity","tag-prematuro","tag-retinopathy","tag-retinopatia"],"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/comments?post=2389"}],"version-history":[{"count":3,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2389\/revisions"}],"predecessor-version":[{"id":9312,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2389\/revisions\/9312"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/media?parent=2389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/categories?post=2389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/tags?post=2389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}